| 隐丹参酮抗纤维化及其机制研究进展 |
| 投稿时间：2022-08-14 修订日期：2022-11-18 点此下载全文 |
| 引用本文：刘亚谊,张俊平.隐丹参酮抗纤维化及其机制研究进展[J].药学实践杂志,2023,41(3):146~148,186 |
| 摘要点击次数: 600 |
| 全文下载次数: 482 |
|
| 基金项目:福建中医药大学高层次人才科研启动资金项目（X2019005） |
|
| 中文摘要:隐丹参酮（CTS）作为一种高效低毒的天然化合物，在各器官组织中具有良好的抗纤维化作用，但目前其作用机制尚未明确，且无系统的文献综述对其抗纤维化潜在机制进行描述。笔者综述了隐丹参酮治疗各脏器纤维化的疗效及其机制，并提出了未来展望。 |
| 中文关键词:隐丹参酮 肾纤维化 肺纤维化 心纤维化 肝纤维化 作用机制 |
| |
| Research progress of cryptotanshinone on anti-fibrosis and its mechanism |
|
|
| Abstract:As a natural compound with high efficiency and low toxicity, cryptotanshinone (CTS) has a good anti-fibrosis effect in various organs and tissues. However, its mechanism of action has not been clearly defined, and there is no systematic literature review to describe its potential anti-fibrosis mechanism. The efficacy and mechanism of cryptotanshinone in the treatment of fibrosis in various organs were summarized and the use prospects were put forward in this paper. |
| keywords:cryptotanshinone renal fibrosis pulmonary fibrosis cardiac fibrosis liver fibrosis mechanism |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
